An interventional study of etafilcon A multifocal contact lens and etafilcon A Contact Lens in Presbyopia, sponsored by Johnson & Johnson Vision Care, Inc.. Completed at 8 sites in United States. Open to participants aged 35 Years to 47 Years. Per ClinicalTrials.gov, last updated 2018-06-19.
Sponsored by Johnson & Johnson Vision Care, Inc. · Not applicable, Interventional, and Treatment
The purpose of this study is to evaluate the effect of a multi-focal contact lens on symptomatic patients.
324 studies on the registry are indexed under Presbyopia; 33 are open to participants now.
This study's enrollment of 49 is below the median of 61 across 265 interventional studies indexed under Presbyopia.
Browse Presbyopia studies →Johnson & Johnson Vision Care, Inc. is the lead sponsor of 220 studies on the registry; 2 are open to participants now.
Of its 110 completed or terminated interventional studies of FDA-regulated products, 101 (92%) have results posted.
Counted across the registry records on this site, refreshed daily.
Have normal eyes with no evidence of abnormality or disease. For the purpose of this study a normal eye is defined as one having:
Exclusion Criteria:
period 1: etafilcon A multifocal worn, period 2: etafilcon A sphere worn.
Device: etafilcon A multifocal contact lens · Device: etafilcon A Contact Lens
period 1: etafilcon A sphere worn, period 2: etafilcon A multifocal worn.
Device: etafilcon A multifocal contact lens · Device: etafilcon A Contact Lens
low-add multifocal contact lens
standard sphere contact lens
Subject Reported Overall Vision Quality Using (CLUE)TM Questionnaire
The Contact Lens User Experience (CLUE) Questionnaire is a validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response, with scores ranging from 0-120.
Time frame: week 4
Monocular Amplitude of Accommodation
The amplitude of accommodation is a measure of the eyes ability to accommodate or focus on near objects. The method used was the push-up/push-down method performed monocularly. One eye was occluded and using the smallest print the subject was able to read, the reading chart was slowly moved towards the subject. The subject was asked them to indicate when the print first becomes blurred. The distance was noted and the amplitude of accommodation was calculated.
Time frame: week 4
Proportion of Subjects With Near Vision Symptoms as Assessed by the NVQ
Proportion of subjects reporting frequent/constant near vision problem per the Near Vision Questionnaire (NVQ). The NVQ was used to assess subjects' near vision problems. Subjects graded each question using a 5-level Likert-type scale (5-levels: never, infrequent, sometimes, frequently, constantly).
Time frame: week 4
Subject Reported Lens Comfort Using CLUE Questionnaire
Subject reported lens comfort was assessed using the CLUE Questionnaire. CLUE is a validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response. Scores range from 0 -120.
Time frame: week 4
Comfortable Wearing Time
Comfortable wearing time was measured using self-reported subject awareness of irritation at a given time of day, rounded to the nearest half-hour. Could be described as aware of issue or completely comfortable.
Time frame: week 4
Proportion of Subjects Benefiting From the Binocular +/-1.00D Accommodative Flipper
Utility of the use of the Binocular +/-1.00D accommodative flipper as a screening tool for those emerging presbyopia subjects
Time frame: Baseline
This was a four week, 49 subject, doubly-masked, daily wear, two-part crossover study. Recruited patients were emerging presbyopic (35-47 years) and soft CL wearing who were experiencing any near vision symptoms.
| Milestone | Etafilcon A Multifocal/ Etafilcon A Sphere | Etafilcon A Sphere/ Etafilcon A Multifocal |
|---|---|---|
| Started | 25 | 24 |
| Completed | 25 | 24 |
| Not completed | 0 | 0 |
| Milestone | Etafilcon A Multifocal/ Etafilcon A Sphere | Etafilcon A Sphere/ Etafilcon A Multifocal |
|---|---|---|
| Started | 25 | 24 |
| Completed | 25 | 24 |
| Not completed | 0 | 0 |
The Contact Lens User Experience (CLUE) Questionnaire is a validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response, with scores ranging from 0-120.
| units on a scale | Etafilcon A Multifocal | Etafilcon A Sphere |
|---|---|---|
| Subject Reported Overall Vision Quality Using (CLUE)TM Questionnaire | 41.0 (30.0 to 51.0) | 39.0 (28.0 to 50.0) |
The amplitude of accommodation is a measure of the eyes ability to accommodate or focus on near objects. The method used was the push-up/push-down method performed monocularly. One eye was occluded and using the smallest print the subject was able to read, the reading chart was slowly moved towards the subject. The subject was asked them to indicate when the print first becomes blurred. The distance was noted and the amplitude of accommodation was calculated.
| diopters | Etafilcon A Multifocal | Etafilcon A Sphere |
|---|---|---|
| Monocular Amplitude of Accommodation | 0.00 (-0.075 to 0.025) | 0.00 (-0.075 to 0.01) |
Proportion of subjects reporting frequent/constant near vision problem per the Near Vision Questionnaire (NVQ). The NVQ was used to assess subjects' near vision problems. Subjects graded each question using a 5-level Likert-type scale (5-levels: never, infrequent, sometimes, frequently, constantly).
| percentage of participants | Etafilcon A Multifocal | Etafilcon A Sphere |
|---|---|---|
| Proportion of Subjects With Near Vision Symptoms as Assessed by the NVQ | 53 | 43 |
Subject reported lens comfort was assessed using the CLUE Questionnaire. CLUE is a validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response. Scores range from 0 -120.
| units on a scale | Etafilcon A Multifocal | Etafilcon A Sphere |
|---|---|---|
| Subject Reported Lens Comfort Using CLUE Questionnaire | 59.0 (38.0 to 75.0) | 59.0 (50.0 to 77.0) |
Comfortable wearing time was measured using self-reported subject awareness of irritation at a given time of day, rounded to the nearest half-hour. Could be described as aware of issue or completely comfortable.
| hours | Etafilcon A Multifocal | Etafilcon A Sphere |
|---|---|---|
| Comfortable Wearing Time | 14 (11 to 15) | 14 (12 to 14.5) |
Utility of the use of the Binocular +/-1.00D accommodative flipper as a screening tool for those emerging presbyopia subjects
| percentage of participants | Etafilcon A Multifocal | Etafilcon A Sphere |
|---|---|---|
| Proportion of Subjects Benefiting From the Binocular +/-1.00D Accommodative Flipper | 52 | 58 |
Non-serious events are listed at a 5% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Etafilcon A Multifocal | — | 0/49 (0%) | 0/49 (0%) |
| Etafilcon A Sphere | — | 0/49 (0%) | 0/49 (0%) |
| Age, Categorical(Participants) | Etafilcon A Multifocal/ Etafilcon A Sphere | Etafilcon A Sphere\ Etafilcon A Multifocal | Total |
|---|---|---|---|
| <=18 years | 0 | 0 | 0 |
| Between 18 and 65 years | 25 | 24 | 49 |
| >=65 years | 0 | 0 | 0 |
| Age, Continuous(years) | Etafilcon A Multifocal/ Etafilcon A Sphere | Etafilcon A Sphere\ Etafilcon A Multifocal | Total |
|---|---|---|---|
| Mean | 42.3 ± 3.4 | 42.3 ± 3.4 | 42.3 ± 3.4 |
| Sex: Female, Male(Participants) | Etafilcon A Multifocal/ Etafilcon A Sphere | Etafilcon A Sphere\ Etafilcon A Multifocal | Total |
|---|---|---|---|
| Female | 18 | 18 | 36 |
| Male | 7 | 6 | 13 |
This study is completed, as verified in Aug 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Johnson & Johnson Vision Care, Inc.